MD Anderson Cancer Center Madrid – Hospiten launches a platform to predict toxicity of chemotherapy Published on 20/09/2019 The analysis of these results, easily obtainable through a simple blood sample, allows the healthcare professional to adjust the doses or opt for other treatments that are less toxic for the patient